WHO TRS (Technical Report Series) 970, 2012 Annex 1

Development of monographs for The International Pharmacopoeia

The process described below is designed to ensure wide consultation and transparency during monograph development and that the adopted texts are made available in a timely manner. 

Provision of monographs in The International Pharmacopoeia provides the quality dimension for the medicines (included on the basis of their efficacy and safety) in the World Health Organization (WHO) Model lists of essential medicines and in WHO treatment guidelines. 

Major WHO programmes such as the Prequalification of Medicines Programme (funded by the Bill & Melinda Gates Foundation and UNITAID) and others funded or managed by partner organizations such as the United Nations Children’s Fund and the Global Fund to Fight AIDS, Tuberculosis and Malaria, rely heavily upon the quality specifications of The International Pharmacopoeia.

See the pdf file for complete details:

WHO TRS (Technical Report Series) 970, 2012 Annex 1: